FinTrust Capital Advisors’s Invesco Biotechnology & Genome ETF PBE Stock Holding History

FinTrust Capital Advisors’s Portfolio PBE Stock Details PBE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	$6.28K	Hold	90	–	–	﹤0.01%	1048
2024 Q2	$5.83K	Sell	90 -226	-72%	-$14.3K	﹤0.01%	1009
2024 Q1	$20.5K	Hold	316	–	–	﹤0.01%	728
2023 Q4	$20.8K	Hold	316	–	–	﹤0.01%	691
2023 Q3	$18K	Hold	316	–	–	﹤0.01%	677
2023 Q2	$20.1K	Hold	316	–	–	﹤0.01%	654
2023 Q1	$20.1K	Hold	316	–	–	﹤0.01%	651
2022 Q4	$20.1K	Hold	316	–	–	﹤0.01%	649
2022 Q3	$20K	Hold	316	–	–	0.01%	720
2022 Q2	$19K	Hold	316	–	–	﹤0.01%	748
2022 Q1	$20K	Hold	316	–	–	﹤0.01%	766
2021 Q4	$23K	Hold	316	–	–	0.01%	715
2021 Q3	$24K	Hold	316	–	–	0.01%	693
2021 Q2	$24K	Hold	316	–	–	0.01%	717
2021 Q1	$23K	Hold	316	–	–	0.01%	678
2020 Q4	$22K	Hold	316	–	–	0.01%	662
2020 Q3	$18	Hold	316	–	–	﹤0.01%	677
2020 Q2	$18K	Hold	316	–	–	0.01%	641
2020 Q1	$15K	Hold	316	–	–	0.01%	688
2019 Q4	$18K	Hold	316	–	–	0.01%	658
2019 Q3	$15K	Hold	316	–	–	0.01%	697
2019 Q2	$17K	Hold	316	–	–	0.01%	640
2019 Q1	$17K	Hold	316	–	–	0.01%	649
2018 Q4	$15K	Buy	+316	New	+$16.2K	0.01%	674

Other funds holding PBE

GKWIM

Gerber Kawasaki Wealth & Investment Management Santa Monica, California $3.14B AUM 22.62% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

CreativeOne Wealth Overland Park, Kansas $4.31B AUM 19.42% 1-Year Est. Return

YIA

YHB Investment Advisors West Hartford, Connecticut $1.56B AUM 27.39% 1-Year Est. Return

OCM

One Capital Management Westlake Village, California $3.65B AUM 15.32% 1-Year Est. Return

FinTrust Capital Advisors's PBE Position: Q3 2024 in Review

FinTrust Capital Advisors held its Invesco Biotechnology & Genome ETF (PBE) position steady in Q3 2024 at 90 shares worth $6.28K. The position accounts for ﹤0.01% of the portfolio, ranked #1048.

FinTrust Capital Advisors first reported a position in PBE in Q4 2018 and has held it in 24 quarters since. The position peaked at $24K in Q3 2021. 102 funds tracked by Wall St. Rank hold PBE as of Q3 2024.

FinTrust Capital Advisors held 90 shares of Invesco Biotechnology & Genome ETF worth $6.28K as of Q3 2024.
FinTrust Capital Advisors left its Invesco Biotechnology & Genome ETF share count unchanged in Q3 2024.
Invesco Biotechnology & Genome ETF made up ﹤0.01% of FinTrust Capital Advisors's portfolio in Q3 2024, its #1048 holding.
FinTrust Capital Advisors first reported a position in Invesco Biotechnology & Genome ETF in Q4 2018 and has held it in 24 quarters since.
FinTrust Capital Advisors's Invesco Biotechnology & Genome ETF position peaked at $24K in Q3 2021.
102 funds tracked by Wall St. Rank held Invesco Biotechnology & Genome ETF as of Q3 2024.

Based on FinTrust Capital Advisors's 13F filing for Q3 2024, filed 11 Oct 2024.